Dermoscopic Evaluation of Mild-to-Moderate Acne Vulgaris: A Correlation Analysis with Clinical Severity Scales

轻中度寻常痤疮的皮肤镜评估:与临床严重程度评分的相关性分析

阅读:2

Abstract

BACKGROUND: Acne vulgaris is a chronic inflammatory disorder of the pilosebaceous unit. Accurate and objective assessment of inflammatory activity remains a challenge in clinical practice. Dermoscopy, as a noninvasive imaging technique, enables visualization of vascular and color changes associated with inflammation. METHODS: In this cross-sectional study, 40 patients with mild-to-moderate acne vulgaris were enrolled, and 80 dermoscopic images were obtained. Background color, vascular morphology, vascular distribution, and perifollicular yellow halo were analyzed and compared between severity grades (mild vs. moderate) and among lesion types (comedonal, papular, pustular). RESULTS: In the mild group, a light-red background predominated (41.7%), whereas red and dark-red backgrounds were more common in the moderate group (both 38.6%), with a significant difference (χ(2) = 10.13, P = 0.006). Vascular morphology suggested a trend toward transition from dotted to branched forms with increasing inflammation, although this did not reach statistical significance (P > 0.05). By lesion type, comedonal lesions mainly displayed light-red backgrounds with dotted vessels, while papular and pustular lesions exhibited red-to-dark-red backgrounds with branched or atypical vessels (P < 0.05). CONCLUSION: Progressive deepening of background color and transformation of vascular morphology on dermoscopy are associated with increasing inflammatory activity in acne vulgaris. Quantitative evaluation of these dermoscopic parameters may contribute to preliminary objective severity grading and therapeutic monitoring. Dermoscopy may represent a potentially valuable, noninvasive imaging modality for assessing inflammatory activity in acne.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。